Literature DB >> 29733745

Development and validation of the Working Alliance Inventory Dutch version for use in rehabilitation setting.

Davy Paap1,2,3, Ernst Schrier3, Pieter U Dijkstra3,4.   

Abstract

Background: In rehabilitation, therapeutic alliance is associated with improvements in clinical outcomes. The Working Alliance Inventory (WAI) measures therapeutic alliance and is frequently used in rehabilitation research; however, it has not been validated for rehabilitation.
Objectives: To determine content validity, internal consistency and construct validity of the Working Alliance Inventory Rehabilitation Dutch Version (WAI-ReD).
Methods: In phase 1, content and face validity of the WAI-ReD was judged by professionals (n = 15) and in phase 2 by patients (n = 22). In phase 3, 14 hypotheses were tested in patients (n = 138) regarding: content validity (i.e., missing items, floor, and ceiling effects); internal consistency; and construct validity (i.e., factor structural testing correlations of WAI-ReD scores with Session Rating Scale (SRS), the Helping Alliance Questionnaire II (HAQ-II), and Visual Analog Scale of Pain (VASpain)).
Results: After phase 1 and phase 2, the WAI-ReD was formulated and tested. Content validity; missing items were negligible. Ceiling effects were present in all domains. Internal consistency; Cronbach's α ranged between 0.804 and 0.927. Construct validity; correlations between WAI-ReD, SRS, HAQ-II, and VASpain fell within the hypothesized ranges.
Conclusion: Eleven of the 14 hypotheses were not rejected confirming good clinimetric properties of the WAI-ReD. The WAI-ReD can be used in rehabilitation to measure therapeutic alliance.

Entities:  

Keywords:  Therapeutic alliance; assessment and rehabilitation; measurement properties; working alliance

Mesh:

Year:  2018        PMID: 29733745     DOI: 10.1080/09593985.2018.1471112

Source DB:  PubMed          Journal:  Physiother Theory Pract        ISSN: 0959-3985            Impact factor:   2.279


  6 in total

1.  Exploring the therapeutic alliance in Belgian family medicine and its association with doctor-patient characteristics: a cross-sectional survey study.

Authors:  Pauline Boeckxstaens; Annelou Meskens; Aline Van der Poorten; Anne-Catherine Verpoort; Elizabeth Ann Sturgiss
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

2.  Efficacy of Acceptance and Commitment Therapy in Daily Life (ACT-DL) in early psychosis: study protocol for a multi-centre randomized controlled trial.

Authors:  Ulrich Reininghaus; Annelie Klippel; Henrietta Steinhart; Thomas Vaessen; Martine van Nierop; Wolfgang Viechtbauer; Tim Batink; Zuzana Kasanova; Evelyne van Aubel; Ruud van Winkel; Machteld Marcelis; Therese van Amelsvoort; Mark van der Gaag; Lieuwe de Haan; Inez Myin-Germeys
Journal:  Trials       Date:  2019-12-26       Impact factor: 2.279

3.  The Working Alliance Inventory's Measurement Properties: A Systematic Review.

Authors:  Davy Paap; Yasmaine H J M Karel; Arianne P Verhagen; Pieter U Dijkstra; Jan H B Geertzen; Grieteke Pool
Journal:  Front Psychol       Date:  2022-07-15

4.  User Experience and Potential Health Effects of a Conversational Agent-Based Electronic Health Intervention: Protocol for an Observational Cohort Study.

Authors:  Marian Z M Hurmuz; Stephanie M Jansen-Kosterink; Harm Op den Akker; Hermie J Hermens
Journal:  JMIR Res Protoc       Date:  2020-04-03

5.  Improving mental wellbeing of forensic psychiatric outpatients through the addition of an informal social network intervention to treatment as usual: a randomized controlled trial.

Authors:  L T A Swinkels; T M van der Pol; A Popma; J F Ter Harmsel; J J M Dekker
Journal:  BMC Psychiatry       Date:  2020-08-25       Impact factor: 3.630

6.  COMmunity PARticipation through Education (COMPARE): effectiveness of supported education for students with mental health problems, a mixed methods study - study protocol for a randomized controlled trial.

Authors:  Jacomijn Hofstra; Jorien van der Velde; Petra Jannette Havinga; Lies Korevaar
Journal:  BMC Psychiatry       Date:  2021-07-03       Impact factor: 3.630

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.